Literature DB >> 31740931

Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection.

Ashwin Balagopal1, Hyon S Hwang1, Tanner Grudda1, Jeffrey Quinn1, Richard K Sterling2, Mark S Sulkowski1, Chloe L Thio1.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) is a leading cause of liver failure and hepatocellular carcinoma. Approximately 10% of people with HIV also have HBV and are at higher risk of liver disease progression than in HBV monoinfection. Antivirals, common to HIV and HBV, suppress HBV DNA levels but do not eradicate virus because the transcriptional template, covalently closed circular DNA (cccDNA), is long lived in infected hepatocytes.
METHODS: Using single-cell laser capture microdissection, we isolated >1100 hepatocytes from 5 HIV/HBV coinfected persons with increasing exposure to HBV antivirals (HB1-HB5; no exposure to >7 years exposure), quantifying cccDNA and pregenomic RNA (pgRNA) in each cell using droplet digital polymerase chain reaction.
RESULTS: The proportion of infected hepatocytes decreased with antiviral exposure from 96.4% (HB1) to 29.8% (HB5). Upper cccDNA range and median pgRNA decreased from HB1 to HB5 (P < .05 for both). The amount of pgRNA transcribed per cccDNA also decreased from HB1 to HB5 (P < .05). Cells with inactive pgRNA transcription were enriched from 0% (HB1) to 14.3% (HB5) of infected hepatocytes.
CONCLUSIONS: cccDNA transcription is reduced in HIV/HBV coinfected people with longer antiviral duration. Understanding HBV transcriptional regulation may be critical to develop a functional cure.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HBV transcription; HIV/HBV coinfection; intrahepatic hepatitis B; single-cell laser capture microdissection; viral landscape; viroscape

Mesh:

Substances:

Year:  2020        PMID: 31740931      PMCID: PMC7137881          DOI: 10.1093/infdis/jiz607

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.

Authors:  Andreas Laras; John Koskinas; Evangelini Dimou; Ageliki Kostamena; Stephanos J Hadziyannis
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

Authors:  Laura Belloni; Teresa Pollicino; Francesca De Nicola; Francesca Guerrieri; Giuseppina Raffa; Maurizio Fanciulli; Giovanni Raimondo; Massimo Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

3.  In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Authors:  Xiaonan Zhang; Wei Lu; Ye Zheng; Weixia Wang; Lu Bai; Liang Chen; Yanling Feng; Zhanqing Zhang; Zhenghong Yuan
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

Review 4.  HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.

Authors:  Michael Nassal
Journal:  Gut       Date:  2015-06-05       Impact factor: 23.059

5.  Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1.

Authors:  Ji-Hua Ren; Ying Tao; Zhen-Zhen Zhang; Wei-Xian Chen; Xue-Fei Cai; Ke Chen; Ben C B Ko; Chun-Li Song; Long-Kuan Ran; Wan-Yu Li; Ai-Long Huang; Juan Chen
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 6.  Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.

Authors:  Marcus M Mücke; Lisa I Backus; Victoria T Mücke; Nicola Coppola; Carmen M Preda; Ming-Lun Yeh; Lydia S Y Tang; Pamela S Belperio; Eleanor M Wilson; Ming-Lung Yu; Stefan Zeuzem; Eva Herrmann; Johannes Vermehren
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-01-19

7.  HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Authors:  William S Mason; Upkar S Gill; Samuel Litwin; Yan Zhou; Suraj Peri; Oltin Pop; Michelle L W Hong; Sandhia Naik; Alberto Quaglia; Antonio Bertoletti; Patrick T F Kennedy
Journal:  Gastroenterology       Date:  2016-07-22       Impact factor: 22.682

Review 8.  HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Authors:  Thomas Tu; Magdalena A Budzinska; Nicholas A Shackel; Stephan Urban
Journal:  Viruses       Date:  2017-04-10       Impact factor: 5.048

9.  Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation.

Authors:  Vanessa C McFadden; Rasha E Shalaby; Saira Iram; Claudia E Oropeza; Jennifer A Landolfi; Alexander V Lyubimov; Mark Maienschein-Cline; Stefan J Green; Klaus H Kaestner; Alan McLachlan
Journal:  PLoS Pathog       Date:  2017-02-24       Impact factor: 6.823

10.  Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression.

Authors:  Suofeng Sun; Kenji Nakashima; Masahiko Ito; Yuan Li; Takeshi Chida; Hirotaka Takahashi; Koichi Watashi; Tatsuya Sawasaki; Takaji Wakita; Tetsuro Suzuki
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

View more
  7 in total

1.  When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 2.  Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection.

Authors:  Tobias Boettler; Upkar S Gill; Lena Allweiss; Teresa Pollicino; John E Tavis; Fabien Zoulim
Journal:  JHEP Rep       Date:  2022-04-02

3.  Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients.

Authors:  Fanny Lebossé; Aurore Inchauspé; Maëlle Locatelli; Clothilde Miaglia; Audrey Diederichs; Judith Fresquet; Fleur Chapus; Kamal Hamed; Barbara Testoni; Fabien Zoulim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

4.  Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment.

Authors:  Tanner Grudda; Hyon S Hwang; Maraake Taddese; Jeffrey Quinn; Mark S Sulkowski; Richard K Sterling; Ashwin Balagopal; Chloe L Thio
Journal:  J Clin Invest       Date:  2022-09-15       Impact factor: 19.456

Review 5.  Epigenetic modulation in chronic hepatitis B virus infection.

Authors:  Maura Dandri
Journal:  Semin Immunopathol       Date:  2020-03-17       Impact factor: 9.623

6.  Single hepatocytes show persistence and transcriptional inactivity of hepatitis B.

Authors:  Ashwin Balagopal; Tanner Grudda; Ruy M Ribeiro; Yasmeen S Saad; Hyon S Hwang; Jeffrey Quinn; Michael Murphy; Kathleen Ward; Richard K Sterling; Yang Zhang; Alan S Perelson; Mark S Sulkowski; William O Osburn; Chloe L Thio
Journal:  JCI Insight       Date:  2020-10-02

7.  Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.

Authors:  Lena Allweiss; Katja Giersch; Andrea Pirosu; Tassilo Volz; Robert C Muench; Rudolf K Beran; Stephan Urban; Hassan Javanbakht; Simon P Fletcher; Marc Lütgehetmann; Maura Dandri
Journal:  Gut       Date:  2021-01-28       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.